Copyright ©The Author(s) 2015.
World J Hepatol. Feb 27, 2015; 7(2): 177-188
Published online Feb 27, 2015. doi: 10.4254/wjh.v7.i2.177
Figure 1
Figure 1 Summary of the potential stimuli that may affect iron homeostasis in non-alcoholic fatty liver disease. Both, increasing and decreasing stimuli have been reported in non-alcoholic fatty liver disease and it appears likely that the net balance of these frequently counteracting forces finally determines the iron phenotype in the individual. Patterns of iron deposition may also be linked to distinct clinical consequences. IL-6: Interleukin 6; TNF-α: Tumor necrosis factor-α; LPS: Lipopolysaccharide; ER: Endoplasmatic reticulum; A1AT: α-1-antitrypsin; PPARGC1A: Peroxisome proliferator-activated receptor gamma coactivator 1-α; TMPRSS6: Transmembrane protease, serine 6; ESLD: End-stage liver disease; EGF: Epidermal growth factor; PDGF-BB: Platelet derived growth factor BB.